Development of Peptide-Based Vaccines for Cancer

被引：83

作者：

Abd-Aziz, Noraini ^{[1
]}

Poh, Chit Laa ^{[1
]}

机构：

[1] Sunway Univ, Ctr Virus & Vaccine Res CVVR, Sch Med & Life Sci, Subang Jaya 47500, Selangor, Malaysia

来源：

JOURNAL OF ONCOLOGY | 2022年 / 2022卷

关键词：

T-CELL RESPONSES; RANDOMIZED CONTROLLED-TRIAL; LOW-DOSE CYCLOPHOSPHAMIDE; COLONY-STIMULATING FACTOR; IMMUNE-RESPONSE; ANTIGEN PRESENTATION; CHECKPOINT BLOCKADE; CATIONIC LIPOSOMES; PROSTATE-CANCER; DENDRITIC CELLS;

D O I：

10.1155/2022/9749363

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Peptides cancer vaccines are designed based on the epitope peptides that can elicit humoral and cellular immune responses targeting tumor-associated antigens (TAAs) or tumor-specific antigens (TSAs). In order to develop a clinically safe and more effective vaccine for the future, several issues need to be addressed, and these include the selection of optimal antigen targets, adjuvants, and immunization regimens. Another emerging approach involves the use of personalized peptide-based vaccines based on neoantigens to enhance antitumor response. Rationally designed combinatorial therapy is currently being investigated with chemotherapeutic drugs or immune checkpoint inhibitor therapies to improve the efficacy. This review discusses an overview of the development of peptide-based vaccines, the role of adjuvants, and the delivery systems for peptide vaccines as well as combinatorial therapy as potential anticancer strategies.

引用

页数：17

共 152 条

[1] Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma-Five-Year Follow Up of a Phase I/IIa Trial [J].

Aamdal, Elin ;

Inderberg, Else Marit ;

Ellingsen, Espen Basmo ;

Rasch, Wenche ;

Brunsvig, Paal Fredrik ;

Aamdal, Steinar ;

Heintz, Karen-Marie ;

Vodak, Daniel ;

Nakken, Sigve ;

Hovig, Eivind ;

Nyakas, Marta ;

Guren, Tormod Kyrre ;

Gaudernack, Gustav .

FRONTIERS IN IMMUNOLOGY, 2021, 12

[2] Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy [J].

Abdollahi, Amir ;

Folkman, Judah .

DRUG RESISTANCE UPDATES, 2010, 13 (1-2) :16-28

[3] MUC1 as a target antigen for cancer immunotherapy [J].

Acres, B ;

Limacher, JM .

EXPERT REVIEW OF VACCINES, 2005, 4 (04) :493-502

[4] A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].

Ambrosini, G ;

Adida, C ;

Altieri, DC .

NATURE MEDICINE, 1997, 3 (08) :917-921

[5] Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs [J].

Ammi, Rachid ;

De Waele, Jorrit ;

Willemen, Yannick ;

Van Brussel, Ilse ;

Schrijvers, Dorien M. ;

Lion, Eva ;

Smits, Evelien L. J. .

PHARMACOLOGY & THERAPEUTICS, 2015, 146 :120-131

[6] Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma [J].

Andtbacka, Robert H. I. ;

Kaufman, Howard L. ;

Collichio, Frances ;

Amatruda, Thomas ;

Senzer, Neil ;

Chesney, Jason ;

Delman, Keith A. ;

Spitler, Lynn E. ;

Puzanov, Igor ;

Agarwala, Sanjiv S. ;

Milhem, Mohammed ;

Cranmer, Lee ;

Curti, Brendan ;

Lewis, Karl ;

Ross, Merrick ;

Guthrie, Troy ;

Linette, Gerald P. ;

Daniels, Gregory A. ;

Harrington, Kevin ;

Middleton, Mark R. ;

Miller, Wilson H., Jr. ;

Zager, Jonathan S. ;

Ye, Yining ;

Yao, Bin ;

Li, Ai ;

Doleman, Susan ;

VanderWalde, Ari ;

Gansert, Jennifer ;

Coffin, Robert S. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (25) :2780-U98

[7]

[Anonymous], 2013, J. Immunother. Cancer, DOI DOI 10.1186/2051-1426-1-S1-O15

[8] A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice [J].

Arab, Atefeh ;

Behravan, Javad ;

Razazan, Atefeh ;

Gholizadeh, Zahra ;

Nikpoor, Amin Reza ;

Barati, Nastaran ;

Mosaffa, Fatemeh ;

Badiee, Ali ;

Jaafari, Mahmoud Reza .

JOURNAL OF DRUG TARGETING, 2018, 26 (04) :365-372

[9] A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responses [J].

Arbelaez, Carlos A. ;

Estrada, Juan ;

Gessner, Melissa A. ;

Glaus, Charles ;

Morales, Agnieszka B. ;

Mohn, Deanna ;

Phee, Hyewon ;

Lipford, J. Russell ;

Johnston, James A. .

NPJ VACCINES, 2020, 5 (01)

[10] Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4 [J].

Attia, P ;

Phan, GQ ;

Maker, AV ;

Robinson, MR ;

Quezado, MM ;

Yang, JC ;

Sherry, RM ;

Topalian, SL ;

Kammula, US ;

Royal, RE ;

Restifo, NP ;

Haworth, LR ;

Levy, C ;

Mavroukakis, SA ;

Nichol, G ;

Yellin, MJ ;

Rosenberg, SA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :6043-6053

← 1 2 3 4 5 6 7 8 9 10 →